<SEC-DOCUMENT>0001193125-15-116325.txt : 20150401
<SEC-HEADER>0001193125-15-116325.hdr.sgml : 20150401
<ACCEPTANCE-DATETIME>20150401172035
ACCESSION NUMBER:		0001193125-15-116325
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150401
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150401
DATE AS OF CHANGE:		20150401

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTREXON CORP
		CENTRAL INDEX KEY:			0001356090
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36042
		FILM NUMBER:		15744299

	BUSINESS ADDRESS:	
		STREET 1:		1750 KRAFT DRIVE
		STREET 2:		SUITE 1400
		CITY:			BLACKSBURG
		STATE:			VA
		ZIP:			24060
		BUSINESS PHONE:		301-556-9809

	MAIL ADDRESS:	
		STREET 1:		1750 KRAFT DRIVE
		STREET 2:		SUITE 1400
		CITY:			BLACKSBURG
		STATE:			VA
		ZIP:			24060
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d902744d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): April&nbsp;1, 2015 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>INTREXON CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Virginia</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-36042</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>26-0084895</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>20374 Seneca Meadows Parkway, Germantown, Maryland 20876 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(301) 556-9900 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Intrexon Corporation, a Virginia corporation (&#147;Intrexon&#148;), filed
a prospectus supplement to its registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3ASR</FONT> (File No.&nbsp;333-198598) on April&nbsp;1, 2015 covering the resale of shares (the &#147;Shares&#148;) of Intrexon common stock issued
in connection with Intrexon&#146;s entry into (i)&nbsp;a license agreement with ZIOPHARM Oncology, Inc. (&#147;ZIOPHARM&#148;) and The University of Texas System Board of Regents on behalf of The University of Texas M.D. Anderson Cancer Center
(&#147;MD Anderson&#148;) on January&nbsp;13, 2015, (ii)&nbsp;a letter agreement with ZIOPHARM and MD Anderson on January&nbsp;9, 2015 and (iii)&nbsp;related securities issuance agreements dated January&nbsp;13, 2015. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the resale of the Shares, Intrexon is filing the opinion of Troutman Sanders LLP as Exhibit 5.1 to this Current Report on
Form 8-K. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(d)</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits.</B> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the Exhibit Index immediately following the signature page hereto, which
is incorporated herein by reference. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&nbsp;1, 2015 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INTREXON CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Donald P. Lehr</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Donald P. Lehr</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Chief Legal Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Troutman Sanders LLP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Troutman Sanders LLP (included in Exhibit 5.1 above).</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d902744dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g902744ex5_1logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">TROUTMAN&nbsp;SANDERS&nbsp;LLP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Attorneys at Law</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Troutman Sanders
Building</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1001 Haxall Point</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">P.O.
Box 1122 (23218-1122)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Richmond, Virginia 23219</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">804.697.1200 telephone</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April&nbsp;1, 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intrexon Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20374 Seneca Meadows Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Germantown, Maryland 20876 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: <U>Prospectus Supplement
dated April&nbsp;1, 2015</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to Intrexon Corporation, a Virginia corporation (the &#147;<I><U>Company</U></I>&#148;), in connection with the
issuance, offer and sale of up to 2,100,085 shares (the &#147;<I><U>Secondary Shares</U></I>&#148;) of the Company&#146;s common stock, no par value per share (&#147;<I><U>Common Stock</U></I>&#148;) from time to time by the selling shareholders
(the &#147;<I><U>Selling Shareholders</U></I>&#148;) named in the prospectus supplement dated April&nbsp;1, 2015 (together with the Prospectus (as herein defined), the &#147;<I><U>Final Prospectus</U></I>&#148;) filed with the Securities and
Exchange Commission (the &#147;<I><U>Commission</U></I>&#148;) pursuant to Rule 424(b) promulgated under the Securities Act of 1933, as amended (the &#147;<I><U>Act</U></I>&#148;) and the accompanying prospectus dated September&nbsp;5, 2014 (the
&#147;<I><U>Prospectus</U></I>&#148;) that form a part of the registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3ASR</FONT> (the &#147;<I><U>Registration Statement</U></I>&#148;) filed with the Commission on September&nbsp;5,
2014 (File No.&nbsp;333-198598). The Secondary Shares were originally issued by the Company in connection with the Company&#146;s entry into (i)&nbsp;a license agreement with ZIOPHARM Oncology, Inc. (&#147;<I><U>ZIOPHARM</U></I>&#148;) and The
University of Texas System Board of Regents on behalf of The University of Texas M.D. Anderson Cancer Center (&#147;<I><U>MD Anderson</U></I>&#148;) on January&nbsp;13, 2015, (ii)&nbsp;a letter agreement with ZIOPHARM and MD Anderson on
January&nbsp;9, 2015 and (iii)&nbsp;related securities issuance agreements dated January&nbsp;13, 2015 (together, the &#147;<I><U>Transaction Documents</U></I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is being furnished to you at your request in accordance with the requirements of Item&nbsp;601(b)(5)(i) of <FONT
STYLE="white-space:nowrap">Regulation&nbsp;S-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined originals or copies, certified or otherwise identified to our
satisfaction, of such corporate records, agreements, and other instruments, certificates, orders, opinions, correspondence with public officials, certificates provided by the Company&#146;s officers and representatives, and other documents as we
have deemed necessary or advisable for the purposes of rendering the opinion set forth herein, including (i)&nbsp;the corporate and organizational documents of the Company, including the Amended and Restated Articles of Incorporation, as amended to
date (the &#147;<I><U>Articles</U></I>&#148;), and the Bylaws of the Company, as amended to date (the &#147;<I><U>Bylaws</U></I>&#148;), (ii)&nbsp;the resolutions of the Board of Directors of the Company with respect to the Registration Statement,
the Final Prospectus, the Transaction Documents and the issuance of the Secondary Shares to the Selling Shareholders pursuant to the Transaction Documents, (iii)&nbsp;a specimen certificate representing the Common Stock, (iv)&nbsp;the Registration
Statement and exhibits thereto and (v)&nbsp;the Final Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the opinions expressed below, we have assumed
(i)&nbsp;the authenticity of all documents submitted to us as originals, (ii)&nbsp;the conformity to the originals of all documents submitted as certified, photostatic or electronic copies and the authenticity of the originals thereof,
(iii)&nbsp;the legal capacity of natural persons, (iv)&nbsp;the genuineness of signatures not witnessed by us, (v)&nbsp;the due authorization, execution and delivery of all documents by all parties, other than the Company, and the validity, binding
effect and enforceability thereof and (vi)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the records, documents, instruments and certificates we have reviewed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As to any facts material to the opinions expressed herein which were not independently
established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Company and others and of public officials. In making our examination of documents executed or to be executed,
we have assumed that the parties thereto, other than the Company, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or
other, and the execution and delivery by such parties of such documents, and the validity and binding effect thereof on such parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
are members of the bar of the Commonwealth of Virginia and are not purporting to be experts on, or generally familiar with, or qualified to express legal conclusions based upon, laws of any state or jurisdiction other than the federal laws of the
United States of America and the Commonwealth of Virginia and we express no opinion as to the effect of the laws of any other jurisdiction or as to the securities or blue sky laws of any state (including, without limitation, Virginia), municipal law
or the laws of any local agencies within any state (including, without limitation, Virginia). This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing and in reliance thereon, and subject to the limitations, qualifications, assumptions, exceptions and other matters set
forth herein, we are of the opinion that the Secondary Shares have been validly issued and are fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinion
is as of the date hereof and we have no responsibility to update this opinion for events and circumstances occurring after the date hereof or as to facts relating to prior events that are subsequently brought to our attention and we disavow any
undertaking to advise you of any changes in law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion as an exhibit to the Current Report on
Form 8-K and to the use of our name under the caption &#147;Legal Matters&#148; in the Final Prospectus and Registration Statement. In giving this consent, we do not hereby admit that we come within the category of persons whose consent is required
under Section&nbsp;7 of the Act, or the rules or regulations of the Commission promulgated thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Troutman Sanders LLP</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g902744ex5_1logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g902744ex5_1logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@`/P#(`P$1``(1`0,1`?_$`(0```(#`0$!`0``````
M``````8'!`4(``,"`0$!`````````````````````!```0,#`P($`04+"@<!
M`````0(#!!$%!@`2!R$Q02(3"%%A<3(4%8&1H4)2(S.S=!87L<%B<I*R0W,T
M-X+24X,U=38X$0$`````````````````````_]H`#`,!``(1`Q$`/P`Z5ROR
MS=^1,AQG%,?A385BD>B[-D/%E(Z`@*)!\WS:"BY$]P/*6`3H,*_XY;@]/05L
M>A*4X*!6WJ=@IUT!7=LN]PT*TNW)O%;4^VRT7U--3"MPH"=QVI*4U-/#0$W'
M_*-ION(VN[7J7$MEPG-[W(BW4HH0:=`L@Z`E_>[%:T^V(5?A]8:_YM!9LOL/
MMAQAQ+K9[+0H*!^Z-!]D@`DF@'<Z`<G<CX#`E&),R&WL20=JFER&PH'X$5Z:
M"\A3X,Z.F3"D-R8ZQ5+K2PM)^8I)&@KW,OQ5I]QAV[PVWV20ZTI]M*DD=P03
MTIH)EMO%JN;2G;=+9F-H.U:V%I<`/P)23H(DG+\5BON1Y-WALOM':ZTX^VE2
M3\"":Z#I>6XO#<#4N[1([A2E80Z^V@[5"J30D="-!\#,\0+9=%Z@EL=U_6&J
M??W:#ZB9?BLQ]$>+=X;[[AHVTV^VI2C\``:Z#\;S'$W%I;1>(:G%*#:4!]NI
M630)I7O707&@BW&ZVRVM)>N$MJ(TI6U+CZTMI*J5H"HCKH/.WWZR7)QQJWSV
M);C0!=0PXEPI![5VDTT$QQQMMM3CB@AM`)4HF@`'<DZ"-;[O:KDA3EOELRT(
M.U:F%I<`)ZT.TG02776F6ENNK"&FTE2UJ-`$@5))/PT$2W7RS7/>+=.8F%NG
MJ!AQ+FVO:NTFF@DR),>,PN1(<2TPV-SCJSM2D#Q).@K&<QQ1]UIIF\0W'7U;
M&4(?;*E*[4`!ZGKH/FPXC8[%-NLVW,%N3>I)FW!945;WE``D5[#IVT&8/>E_
M];B_[.O]:-!K"$D*M["5"H+201\Z=`GN<L"Q.R\(7QJ!;FT&`TE<-Y0W.-J4
M^DDI6?-XG05'MYXVP:_\3V^9>+/'F2WENI<D.`^H0"*>:M=`-VE^=QM[CHV'
M8[+>?QJ[(;6]:W'%.I9]0*Z)KV*2FOS'077/.>Y!>N0+3Q-C4M4%4Y37VO,:
M-'*.C<&TD=@&^I^?0-C'^(./;):&K8Q98SZ$("77Y#:7775>*EK74DDZ!(\C
MJE\%\@VJ_P"-K<3B%Z<VW.R[BII!!'J>D#]$E)JG00_=E!L2G\.N5OC--_:C
MY6^^TG:7D+*#YR._?0:7QJT6RV6B,S;HK41I33:E(92$`G:.IIH%OR)BN/RN
M6\"6];V%JDKGJE$H!]78RDIW_E;3U%=!8IX7L-RS^_9+D<&//8EIC,6F.HJ4
M&FF&0A>Y%`D$J^%>F@2&48?C,?W4VO'V;<RW9'412Y;TBC*BIJJJIKXG0.R]
M\(8ZWD>.W[&+?&MLRTSFWI>PJ;2Y&!\Z:`*!5\-`B/<;A0&7WV]V!E,/]WF(
M,F0A@;!5U=/5H.E0K;UT&FN*\O9RW`[1>T&KC["4R$C\5U`HL??T"0]T\B1D
M:+E"C+/V=A\5J9,*2:&9,=#32#3\EK>=`Q_;7;[6UQ+8YL:*AJ5):6)+X2`M
MPI=6*J5W.@*>3\B;Q_"+G-*0Z^ZW]6B,G_$>?\B$_AT&?_;TY<N/N7[SQ[>7
M=RI[2'6E"H07@V'*I!^(44C0:H=;;=;6TXD+;<!2M"A4$$4(/SZ#%TA[).)^
M2KSF./QE+P^+=7+;<(B%$IV*.[8H'M_0/QT&N<=R"P9AC;%TMZT2[9/;ZH4`
M1U'F0M/Q'B-`"81BF--<LYOZ5LC($5JT.1@&Q1M:Q*W*1^23L36GPT#6T&1_
M>C_];C'^0K];H-8P/]#'_P`I']T:!>^X[_9;)_V='ZY&@1V$W?FO'^!XU\Q-
M^$_:F%N^K$3'4J6TW^,Z%%12NA\-N@8'MQL>!7Q+V=M3Y%YS%[R7-V>4^K&<
M(ZI0A-`$GP/PT`-*287O,!FIIZ[K2F%*/2BXR=A&@UG709L][#S'[K6%@_IU
MS%*0/':&R#_+H!?W"1Y,;#^*X\JOUAIMI#M>AW!#==!K*V?^-B?Y+?\`=&@`
M\V2%\LX`D*`4D7)=/B`R@?SZ!BZ#+F7_`/['M']2)^JT&H]`GX=BBY+R1R9:
MI0"H\RWQ8"B>NTN,DUI_1)!T"_\`;%E:\4=S'"KXKTS80]/;"S2B&:AU(K]P
MZ";D5HEO>WC+<EG`BY9._P#:3M1Y@REP)80?ZJ!^'0'?M<>]3A:R#_IJD([U
M[/*/\^@KN6LQL@Y(QNP7,O*MMI!N]R3'9<D5=KMC-K2V#3L5==`I.><TLG\0
M<<S_`!H2DR82VTS2_&>C@^DJJ/,M*0:IZ4T&NK5<HUSMD2Y15;HTUEN0RKXH
M=2%)_`=`L<&L%KR#^(UFNK(D0)MX?:?:5\"GN/@1W&@4V+7:]^W[D=>-WQ;D
MG!+TNL.7UHT2:)<'P*:T6/AUT#LP60Q)Y2SJ0PL.L/1;*MIQ)JE25)ED$'0'
MUPF)APGI2FW'@R@K+3(W.*IX)345.@R?[B;=F?(=_L\VP8G=1%M[)2XN0VVV
M5%2]_E2%J[:#1F%YDJ]MIB.V6XVE^.PA3@G-(2BM`"E*TJ5N(^;0"GN`FW"X
MX+>,4M5FGW*Y7%A`97';26$_G$J.Y:E#L$]J:"M]O#UQLV%0,0OEBN$*<%/>
MHX^R@QBDBO584>_:E-`)YOQ9FO'&>LYQQ?%7,@3ED76PH/E%350`J*H5X>*3
MH+//,$O/)*;=G6/6Z1CF<6(H"H-Q2E*7PCSI2'$%5:5H%?<T!=;^;)<>$AG)
M<1O,&]MI"9$>-'3)94X!U+;J5`;5'M70!\GCS,>7,]@9'E]O58</LY"K?9WE
M!<F116ZKH3Y4!9'7Y.F@+/<)Q1/SO$8R;*I+=[LSHDV]M71+@I13=?`TH1H/
M#&.9Y\*S1H&4XI>8E[BMI:>1'CB0TXI`V[D+"A2ORZ"TQ:W9'E.<-YM?+>NS
M6VV17(E@M;Q"I"E2%)+TE[;Y4U"`E*=`?W.>BWP7IBVG7TL)W%EA.]Q7R)34
M5.@S)D,;*YWN&@YY'Q:ZFPQA'2M1:;#I#;82I01O^/RZ#2$7(F9-A7>1#EMM
MH0MPPW&@F2=E>@;W'J:=.N@5_'U^N3'(>4SY^.7:+%O\J.($AQE!0$(1Z=7*
M+JCX^.@!.:^*\H_BW&O>.PY#EIO[:(]]<BI!*&E.)2^%`D?32*Z!G\U(=3QK
M+Q2SV>9<9,Z&&(3<5M)0@(*0/445)V]-`.^WRX7C$N.A8;[C]S8N$);\@)2R
ME27$*(*4H5O^D:]M!;<,KNL[(\KO.1V.9;KQ>98=8,I""VF$T@-L-)6%'J`"
M2*:#T]P]M9O6#S<=C6:9<+G(;#\!R(RE2$/(/E"UE2=M?'05_!V49-8N/8]D
MRK'[HU/LZ2AE2&DN>JP54;"?./,G=2A\!H)7%M_N$3(<B;N&.W6"B^79<F"^
MZR@MAM8Z%PI7Y.WRZ`PY2XVLW(&*2+)<`&WOTD&8!53+X'E4/D/8CX:!4>VB
MP9OB&0Y'9,J@2C]83&;@715%1U(A%T;`JN[J'ZIT&A]!V@!N7N4[9QSBJ[O)
M:,J8\KT;?"!V^HZ14;CX)'<Z`4L6-<XY5;6+U=LQ1C:I:`]'M=NB(<#:%=4I
M<6ZKJ:=Z:"GNV>\O\:9-:+?E;D3)<<O,A,5BZMMF,\VXH]E@%2=U.ORZ!]@U
M`(\>N@'UY_AZ<G&++N;2+^:4MZJAPU3N%.E.J>N@(:Z`7F<FX+"R)..3+NS&
MO3BTM(ANU2I2E_1H2*=?#KH"C0"-TY6P*TSE0;E=4Q)27"T&G$.`J6/Q4>7S
M'YM!Z3N3L+@0(UPFS_J\*4%EF0MMP)HV0%%7E\OTO'05S?.7%#@W-Y%'6FM-
MZ0XI(^Z$Z`DL678Q?F_4L]TCSAXAEP%7]GO^#05N4<EX7BTKZO?K@(*]H7N6
MA9117;S@%/X=!7M\V<7NH"VK\TX@]EH0ZI)^8A.@]K/S#QS>+RQ9+=>&WKG)
M)#$;:M*E$`DTW`>`T$K(>3<'QR8J+?+FBWNH`J7DK"#N[47MVG[^@KD<X<5+
MVD9%'"5?160X$_VBFF@++3>[1>(HEVN8S-C*[.L+"Q^#0>ERNENM<)R;<9+<
M6(T-SC[J@E*0/E.@!3SYQB'*?:;GHU_U7U=[T*?E>IMI3Y=`:66_V6^0TS;1
M-9G15=G65!0^[3MH+"F@ZF@[0=H$E[J.-K[E^'19ED09$VS.*?5#3])QI2:*
MV?%2>]-`MN-_=O/L4>/8<YM;C@B)#(GL@H?"4]!ZK2NY'Q&@T%C^8\:\D06_
MJ$B-=4L+2^(CP'JM+3]%1;5U!'QT!@ZZVPRMUPA#322I:CV"4BIT&,N3'+VU
M>[7S<VM8;FW=UJ.U2@1#B*#,<_\`=0A1T&Q;-<XUUM,.YQE!4>:RV^TH&HVN
M)"A_+H,^>YO`9>69IC<&RA#-\<AS'V7@*+<5%2'$-[AV/2B3X:`B]N_,[V40
MEXIDA+&76E);6ESRJD-M]"JA_'3^-]_07?,K+*LBXY*FTJ)R%L$E(/3T'/CH
M"KDUEE?'N0I6A*D_4'Z)(!'T#X'0*7V?6NV2^+9:I4-A]7VF^FKK:%FGIM=*
MJ!T'C[B>-6,>M?\`$3":V.]6Q:531#_-MNMU^D6T^6J?'IUT'YFV=)SSVM3,
M@D-H$\MMM30D"@D-.I2LIKVW=]`8>VV!;W>&[`MZ,RM90Y52T()_2*[DC06M
MSQK!K[R-;'(2D1,FQ8IGO*CM('J,/)4WZ3BA3O6OQ&@%/=^A!XB<64@K$Z-1
M5!45)['0$W#F/V&=Q+CHFVV+(#D)/J>JRVJM2>]1H%!QD#8O<[?,?Q-:OW85
MO5+B(45,-G:E1IX#:LD#06GNUO$ZWWG$?K[+K^(I>]:Y1VR0EU:%@E"B/Z':
MN@<6'YCQKE]G0U8I$*3#6@)-N*6TE*2*;%,D=/O:"-QUQ7`P:[WZ1:Y!%LO#
MR7V+=MHF.H5W)2:FHZ]-`=Z#M!V@[0#ERS['+=E]NQ.6\IN[W5M3D)!3Y%A`
M)(W?'RZ"OS7A_CS,4+^V[.TN2H?ZUG\R^#\=Z*5_XJZ#+/+W#=XX:N$#+L3N
MSRK<I\-MK4=K[+G500LIHE:%`4[:!YYSR'<Y?"5KF1V5+O\`E;3,./&9'G4X
MZ/SQ0/ZB3H!CD"1.O7$SF&1L#O,9N%&;3"?<2SM;7'3T6JBJ_&N@(O:?F*KW
MQHW:)"ZSK`ZJ(I)[^E7<W4?(#307N7_[Y8+^R7']7H`7W"\4W.W3V^4\'W1K
M]:EA^XL-#](A/=T)'<@?3'B-!\?Q3MG(D;C6XLE+5SCY"TW<X8/F;<^KN>8#
M\E7AH'-R7_M_D/[!(_5G0*OV:?[62_\`VC_ZIK0%_N+FQXG#N1%X@>O']!NO
MBM?1.@1V/VJ7!]GMY>D)*4SGR^P#XM^LE(5]W;H#7@CB?'[YQ99KE)N%W8>?
M2X5M1;@^RS4+(\K:"$IT!OQUQ+^XV;W^Z193LBS7.,T&US'B\^EUM1*PI:NZ
M:=JZ`?\`=VM"^'G%H4%(5-C%*AU!%3VT"[GXORO#X/L=^Q?)ITFWIC!=PLJ4
MM-E#!/\`@N-H#E!UK4UT#0]MLOC*?BJIV*01"NZCMO;;SA>E^MW)4XOS*0KN
M*=-`P<AB85DSC^)7I,:>\6@^[;7#^<2VKH'!2BD_(1H$5EOL^;BO+NG']\D6
MZ:V2MF)(6:`CK1#[>U2?DJ#H)_MZY5SA[+)W'&<I+MW@-K7'E+%'?S--Z'".
MBNAJE6@T0-!V@[0<>V@2_.O'UMR6^V*=`RJ)CV:0%5LL>2\TA4A04"D(;4H.
M$[A^*#\V@F0,WYSM<=$6]8.W>)+8VF?;I:&T.$?C%M84170"'(%BS3D!VW*Y
M(D6[`\&AR`Z8TB6T'I#U"$H4ZX4(KMK3^306S[5Y5R/A\MJWP$XE:VG(F-QQ
M<&?4D*6$@RF4_P"+M;2*!-?CH'+?)DV';'GX<+[0?2.D7>EO</&JE=!H,V\)
MV7*K#R-?+I846RY62Y/+^NVR!<V)+L0+<*DE7IE5"DFG70'632\UD<I8Y=TV
M2,VJVM36H]O=GM(E2D.)VJ<9;(J0D=3T.@;D9]Q^V(>N#`BEQK=*CN*2I*`1
MYDJ5]$@>.@RE>>/+';.8K7D/&M\LER8^N)D&QBY1MZ9`)W--H2LJ5N!.T4J-
M`_>4)V2N8=+AV^TMN&X0G42Y,B2VPS$*D@$N*5W`J>OR:!4\"L\DXIAC]LL%
MMM&21%S''C<8ES;<;2XI"`6R6@X*IV@]_'07F;87DF6B+)Y9O]LQK$8SJ5IM
M,9]+*'7/`/2I"D@GY!H)G,[#T[C%[',:AP&<6=C,"-?G9S#$%II*@4A*U':>
MU`=W700.))?*6/8#;+3:;#;+Y`C!89N<:YH6TZ"LDE);2M/2M.AT$_/)_/-\
MQV5;(UEM]AC24%$^XJF!Q3<<_I2DD(2CRUJ3H*;G2U7>Z<8PL:B(@0[*P(BD
MY#-N##$59;33:A2R`2H]O-H#;A9[((F&VNRW.W1_LV)$*47F-+:DQGT@]T[>
ME"#\::!87/`5P.3OWFX2R"U29+A*KQC[4UEQ*37S@MMK40A1\#]$]M!?7_'\
MUNV>6_+K-.M]DY!A1@U,Q21):=,B*FOG&TAS8L5I5/3XZ`P_B!RRE'H*X]6J
M;2@=3.:^K[OCN(W;=!1<4X=&A\C7C),JOEME<@W%!"K'#?;*XC!H5#TMWJGI
*05(T#KT':#__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
